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In vitro maturation (IVM) of oocyte is an eﬀective procedure for avoiding ovarian hyperstimulation syndrome in patients with
polycystic ovaries (PCOS) during in vitro fertilization (IVF). To investigate the inﬂuences of IVM on epigenetic reprogramming
and to search for the possible reasons for the lower rates of fertilization and cleavage in IVM oocytes, we examined the expression
of two enzymes controlling histone acetylation, histone acetyltransferase GCN5 (GCN5) and histone deacetylase 1 (HDAC1), as
well as their common target, acetyl-histone H3 (Ac-H3), in mouse metaphase II (MII) oocytes and preimplantation embryos.
Results showed that IVM downregulated the protein expression of GCN5 in MII oocytes and two-cell embryos and changed
the distribution of GCN5 in two-cell embryos. Expression of HDAC1 mRNA in MII oocytes and two-cell embryos decreased in
the IVM group. However, none of these changes persisted after two-cell embryos. Levels of Ac-H3 in both oocytes and embryos
remained unchanged after IVM. Our studies indicated that IVM could aﬀect the protein and gene expression related to histone
acetylation in oocytes and early cleavage embryos. By function of selection, parts of the changes could be recovered in late embryo
development.
1.Introduction
In vitro fertilization and embryo transfer (IVF-ET) are an
eﬀective treatment for infertility [1, 2]. However, the high
costs of gonadotropin administration, the risk of ovarian
hyperstimulation syndrome (OHSS), and the possible asso-
ciation between repeated ovarian stimulation and hormone-
related cancers are the main drawbacks of IVF-ET.
In-vitro maturation (IVM) oﬀers an alternative to con-
ventional IVF that minimizes medicine administration and
avoids ovarian hyperstimulation. Meanwhile, poor respon-
ders to gonadotropin stimulation may also beneﬁt from
I V Ma st h e yd on o tn e e dt or e c e i v eal a r g ed o s a g eo f
gonadotropins. With the cryopreservation of reproductive
cells, IVM can oﬀer to preserve fertility in women who are
undergoing cancer treatment [3]. So far more than 1000
children have been born from IVM procedures, particularly
in the patients with PCOS [4, 5]. However, IVM remains
a challenge in mammalian species, especially for human.
Some concern has been voiced regarding the safety of this
new method with respect to the health of the children [6].
Questions have arisen on whether human oocytes matured
in vitro are intrinsically compromised or whether culture
conditions are inadequate to support the full developmental
potential of the oocytes [7].
Oocyte maturation is one of the most critical periods for
normal development and diﬀerentiation for an individual
[8]; however, little is known about the mechanisms that
regulate early folliculogenesis and oocyte maturation in
human. The oocyte genome is epigenetically reprogrammed
duringmeiosis,whichisfollowedbyfertilization,toallowthe
remarkable transformation from diﬀerentiated oocytes into
the totipotent embryos of the next generation [9]. Epigenetic
reprogramming is a scheduled genome-wide modiﬁcation
that occurs in the periods of gametogenesis and embryoge-
nesis, which regulates the gene activity without alteration
of DNA sequences [10]. Epigenetic reprogramming leads
to re-establishment of gene imprinting patterns, silences or2 Obstetrics and Gynecology International
activates genes systematically, and represents a stage suscep-
tive to the changes of environment [11]. Oocyte growth and
maturation appear to be vulnerable to environmental factors
that can induce the epigenetic alteration, deregulation gene
expression, and ultimately, embryo defects or loss.
Although the technique of IVM in human has been
graduallyimproved,itssuccessfulrateremainslowcompared
with IVF. The changes of some imprint genes in the
oocytesorembryosfromIVMsuggestedthatIVMprocedure
might inﬂuence the DNA methylation during the oocyte
maturation in-vitro [12–14]. However, the inﬂuence of IVM
on the process of histone modiﬁcation in oocyte, another
important mechanism in epigenetic reprogramming, has not
been documented.
Histone modiﬁcation includes acetylation and methyla-
tion of lysines (K) and arginines (R), phosphorylation of
serines (S) and threonines (T), ubiquitylation of lysines, as
well as ribosylation. Recent studies have shown that these
histone modiﬁcations play important roles in the regulation
of gene expression in mitotic cells. Some modiﬁcations such
as acetylation of lysine residues in histones H3 upregulate
transcription while other modiﬁcations like methylation of
H3K9 downregulate transcription [15, 16]. Among all the
modiﬁcations, histone acetylation happens most frequently
[17]. Histone acetylation is catalyzed by histone acetyltrans-
ferases (HATs) that transfer acetyl groups from acetyl coen-
zyme A (acetyl-CoA) onto the ε-amino groups of conserved
lysine residues within the core histones. The levels of histone
acetylation in chromatin are determined by the cooperations
of HATs and histone deacetylases (HDACs) [18].
Histone acetyltransferase GCN5 (GCN5), a type-A HAT,
catalyzes the acetylation of nucleosomes in nuclei or free
histones in cytoplasm and acts as transcriptional coactivator
in gene regulation. Histone deacetylase 1 (HDAC1) is one
of Rpd3-like HDACs [19, 20], ﬁrst identiﬁed as an IL-
2 inducible gene. Overexpression of HDAC1 could cause
aberrant morphologies and a partial blockage in the G2/M
phases of the cell cycle [21]. GCN5 and HDAC1 are crucial
forepigeneticreprogramming,regulationofgeneexpression,
and cell proliferation during embryo development, but their
exact roles and the underlying mechanisms during oocytes
maturation in vitro remain unclear. Lysine residues of the
amino terminal tail domain of histone H3 are common
targets for histone acetylation which results in an allosteric
change in the nucleosomal conformation and an increased
accessibility to transcriptional factors by DNA.
The active roles of GCN5 and HDAC1 in epigenetic
reprogramming and embryonic development prompted us
to examine if IVM procedure may have an impact on these
enzymes’ expressions and functions. We determined the
expressionanddistributionofGCN5,HDAC1,andAc-H3in
metaphaseIIoocytesmaturedinvitroandinvivo.Toobserve
the extended eﬀects of IVM, the levels of these factors were
followed in the embryos from IVM and control groups.
2.MaterialsandMethods
2.1. Experimental Animals. Animal care and procedures
were carried out following Institutional Guidance of the
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Figure 1: Rates of fertilization, cleavage, developmental compe-
tence, and birth. Bip: Bipronucleus; BR: total number of born
mice/total number of 2-cell embryos for transplantation. (a) P<
.01; (b) P<. 05.
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Figure 2:mRNAexpressionsofGCN5inoocytesandembryos.The
comparison of GCN5 mRNA expression was made between IVM
and control groups. Summary data showed the relative expression
levels of GCN5 in oocytes and embryos after real-time PCR
analysis. The relative mRNA levels represent the amount of mRNA
expression normalized with GAPDH.
Laboratory Animal of the Animal Care of Usage Committee
(ACUC) of Zhejiang University, and the protocol was
approved by the ACUC of Zhejiang University School of
Medicine. Female ICR mice (6-7 weeks old) and male mice
(8–12 weeks old) were housed in 12/12-hour light/dark cycle
at 25 ± 0.5
◦C and 50–60% humidity. The mice were fed ad
libitum with a standard pellet diet and water. The female
mice are divided into two groups randomly, IVM group and
control group.
2.2. Collection of Oocytes. For IVM group, female mice (6-
7 weeks old) received 5 IU PMSG (pregnant mare serum
gonadotropin; Gestyl, Organon, Oss, The Netherlands) 46–
48 h before being sacriﬁced by cervical dislocation. TheObstetrics and Gynecology International 3
Table 1: Reference genes selected for the study, and sizes of the PCR products.
Genbank
Gene name Accession Primer sequences Product size (bp)
GCN5 NM 020004 5 -CGAGTTGTGCCGTAGCTGTGA-3  96
5 -ACCATTCCCAAGAGCCGGTTA-3 
HDAC1 NM 008228 5 -CTGAATACAGCAAGCAGATGCAGAG-3’ 92
5 -TCCCGTGGACAACTGACAGAAC-3 
GAPDH NM 008084 5 –TGACGTGCCGCCTGGAGAAA-3  98
5 -AGTGTAGCCCAAGATGCCCTTCAG-3 
ovaries wereexcised,andantralfollicleswerepuncturedwith
27G needles in HEPES-buﬀered human tubal ﬂuid medium
(MHTF, Irvin Scientiﬁc, Santa Ana, CA, USA) supplemented
with 10% Quinn’s Advantage Serum Protein Substitute
( S P S ,S A G E / C o o p e r S u r g i c a lI n c . ,T r u m b u l l ,C T ,U S A ) .T h e
cumulus-enclosedoocytesatGVstagewereselected.Oocytes
were matured as previously described [22, 23]. Brieﬂy, GV
stage oocytes were cultured in human tubal ﬂuid (HTF,
Irvin Scientiﬁc, Santa Ana, CA, USA) medium containing
10% SPS supplemented with 0.1IU/ml follicle stimulating
hormone(FSH,GonalF,Serono,Aubonne,Switzerland)and
0.5IU/ml human chorionic gonadotropin (hCG, Pregnyl,
Organon, Oss, The Netherlands) for 16–18 hours at 37
◦Ci n
a humidiﬁed atmosphere of 5% CO2.O o c yt e sw e r eo b s e rv e d
undermicroscopy,andthedisappearanceofgermvesicleand
the extrusion of the ﬁrst polar body were used as the criteria
of the maturation of oocytes.
For the control group, mice were superovulated as
described previously [24]. Brieﬂy, mice received intraperi-
toneal injection of 7.5IU hCG 46–48hrs after the admin-
istration of 7.5IU PMSG. Mice were sacriﬁced by cervi-
cal dislocation 12–14 hours after hCG injection, and the
oviducts were excised. Cumulus masses were recovered from
the dilated ampullae under a dissecting microscope. The
collected cumulus masses were digested with hyaluronidase
to remove granulosa cells. The naked oocytes were either
placed in a drop of HTF for in vitro fertilization or washed
three times with phosphate-buﬀered saline (PBS) for oocyte
ﬁxation or mRNA extraction.
2.3. IVF-ET. Sperm collected from caudal epididymides
of ICR male mice were allowed to disperse in 10% SPS
HTF and incubated at the conditions of 5% CO2,3 7
◦C
for 1hr. For IVF, matured MII oocytes from either IVM
group or the control group were inseminated with 4 ×
105 sperm/ml in drops of 30μlo f1 0 %S P SH T F .A b o u t
4–6hrs after insemination, oocytes were removed from
fertilization medium to fresh 10% SPS HTF [22].
Intactoocyteswereculturedinfresh10%SPSHTFunder
oil at 37
◦Ci n5 %C O 2 in air. Fertilization was judged if the
oocyteshowedextrusionofsecondpolarbodyortheappear-
ance of bi-pronucleus 9hrs after insemination. Two-cell,
four-cell, and eight-cell embryos were harvested for ﬁxation
or mRNA extraction after being washed three times in PBS.
Estrous ICR female mice were mated with vasectomized
males (1 : 1) on the same day as IVF for preparing the
pseudopregnant female mice. Embryos at the 2-cell stage
were transferred into the oviducts (maximum of 15 per
oviduct) of 0.5 d.p.c. pseudopregnant ICR recipient female
miceanesthetizedwith2.5%Avertini.p.Recipientswerekept
warm on a heating pad until fully recovered from anesthesia
[25, 26].
2.4. Quantitative Real-Time RT-PCR. All the pools were
done in triplicate and contained 60 oocytes or embryos
from diﬀerent developmental stages: MII oocytes, 2-cell
embryos, and 8-cells embryos [27]. The total RNA was
extracted from those pools using Absolutely RNA Microprep
Kit (Stratagene, La Jolla, CA, USA) as described by the
manufacturer. The entire RNA pellet was used for the RT.
RT-PCR was carried out using the SYBR PrimeScript RT-
PCR Kit (Takara, China). 4μl 5X PrimeScript Buﬀer PCR
buﬀer, 1μl PrimeScriptTM RT Enzyme Mix I, 1μlO l i g od T
Primer (50μM), and 1μl Random oligos (100 μM) were
added to the pool to obtain a total reaction mix volume of
20μl reaction system. The mixture was incubated at 37
◦Cf o r
15min, andthereaction wasinactivated at85
◦Cf o r5sec.R T
products were ampliﬁed by real-time PCR with SYBR-Green
I (Takara, China) on ABI real-time PCR system (Applied
Biosystems) according to the manufacturer’s instructions.
GAPDH was used as an internal reference gene. Real-time
PCR was carried out in 20μl reactions containing 10μl
SYBR Premix Ex Taq, 0.4μlP C RF o r w a r dP r i m e r( 1 0μM),
0.4μlP C RR e v e r s eP r i m e r( 1 0 μM), 0.4μlR O XR e f e r e n c e
Dye, and 2μl cDNA sample. PCR was performed with one
denaturation cycle at 95
◦C for 10sec and 40 ampliﬁcation
cyclesat 95
◦Cf o r5s eca n d6 0
◦C for 30sec. Primer sequences
for the genes are shown in Table 1. Data were analyzed by the
comparative threshold cycle (CT) method and the standard
formula [28].
2.5. Fluorescence Immunocytochemistry. Immunoﬂuorescent
staining was conducted as previously described [29]. Fol-
lowing ﬁxation in 4% formaldehyde (Sigma, St. Louis,
MO, USA) at 25
◦Cf o r3 0m i n ,o o c y t e sa n de m b r y o s
were permeabilized with 1% Tween-20 in PBS containing
0.1% BSA at 4◦C for 60 min. Nonspeciﬁc binding was
blocked with heat-inactivated sheep serum in PBS (30% v/v)
containing2%BSAat25
◦Cfor30min.Oocytesandembryos
were incubated with antibodies against HDAC1 (rabbit, 1:
200; Upstate Biotechnology Inc., Lake Placid, NY, USA),
GCN5 (goat, 1 : 200; Santa Cruz Biotechnology, Inc., Santa4 Obstetrics and Gynecology International
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Figure 3: Fluorescence immunocytochemistry of GCN5 in oocytes and embryos. (a) Expressions of GCN5 in MII oocytes, 2-cell, 4-cell,
and 8-cell embryos from IVM and control groups. Each sample was counterstained with DAPI (blue) to visualize the DNA. Speciﬁc goat
polyclonalGCN5wasdetectedbyﬂuorescein-conjugatedantigoatsecondaryantibodies(greencolour,FITC-labeled).Barrepresents100μm.
(b) The gray value of GCN5 in oocytes and embryos.
Cruz, CA, USA), or Ac-H3 (rabbit, 1: 800; Cell Signaling
Technology, Inc., Danvers, MA, USA) at 4◦C overnight.
The cells were washed three times with PBS, incubated
in ﬂuorescein isothiocyanate- (FITC- ) labeled secondary
antibody (rabbit antigoat IgG, 1 : 200, for GCN5; goat
anti-rabbit IgG, 1 : 200, for HDAC1 or Ac-H3; Zhongshan
Golden Bridge Biotechnology, Co., Beijing, China) at 25
◦C
for 30 min. The slides were washed, and a drop of DAPI
(VectorLaboratories,Burlingame,CA)wasadded.Theslides
were then sealed with a coverslip. The ﬂuorescent signals
were detected with a Laser-Scanning Confocal Microscopy
(Zeiss, LSM 510 META, Jena, Germany). Instrument settings
were kept constant for each replicate. The ﬂuorescence
images were analyzed by using the program Image-J from
the National Institutes of Health (http://rsb.info.nih.gov/ij/)
(USA). Each developmental panel was repeated three times,
and at least 20 oocytes or embryos were evaluated each time.
In each experiment, samples without primary antibody were
included as negative controls.
3. Results
3.1. IVM Decreased the Rates of Fertilization, Cleavage,
and Developmental Competence. The rates of fertilization,
cleavage, blastulation, and birth were signiﬁcantly lower in
IVM group than those in the control group (P<. 05)Obstetrics and Gynecology International 5
(Figure 1). Meanwhile, 69.13% of 2-cell embryos in IVM
group could develop to 4-cell embryos while 89.21% in the
control group (P<. 05).
3.2. Statistical Analyses. Chi-square test was applied for the
comparison of fertilization and cleavage and early develop-
ment rates. Data of ﬂuorescence immunocytochemistry and
RT-PCR between IVM and control groups was compared by
independent-test using SPSS 16.0 (Statistical Package for the
Social Science, SPSS Inc., Chicago, USA), and P<. 05 was
considered statistically signiﬁcant.
3.3. The mRNA Expression of GCN5. The GCN5 mRNA was
detected in both MII oocytes and embryos. The mRNA
expressions were decreased in IVM oocytes; and embryos,
however, no signiﬁcant statistically diﬀerences were detected
(P<. 05) (Figure 2).
3.4. Localization and Intensity of GCN5. Fluorescence
immunocytochemistry showed that GCN5 was expressed
in oocytes and embryos in both IVM and control groups.
Quantitative analysis showed that the ﬂuorescent signals in
oocytes and the cytoplasm of blastomeres in 2-cell embryo
in IVM group were signiﬁcantly lower than those in the
control group (P<. 01). Meanwhile, in the 2-cell embryos of
the control group, GCN5 expression was obviously around
karyotheca while in the same stage of embryo from IVM, the
distribution of the ﬂuorescent staining of GCN5 was almost
even. However, after 2-cell stage embryos, no signiﬁcant
diﬀerence was found in the ﬂuorescent intensities and
distributions of GCN5 (Figure 3).
3.5. The mRNA Expression of HDAC1. The HDAC1 mRNA
was expressed in both MII oocytes and embryos. The mRNA
expressionwassigniﬁcantlylowerintheIVMgroupthanthat
in the control group in oocytes and 2-cell embryos (P<. 05)
(Figure4).Thistrendcontinuesinthe4-celland8-cellstages,
but the diﬀerences did not reach a statistically signiﬁcant
level.
3.6.LocalizationandIntensityof HDAC1. Theintensities and
localizations of HDAC1 in the cytoplasm of MII oocytes and
two-cell embryos were not signiﬁcantly diﬀerent between
IVM and the control groups. But in the nuclei of 2-cell
embryos, the mean gray value of HDAC1 in IVM group was
signiﬁcantly lower than that in the control group (P<. 05).
After 2-cell stage embryos, no signiﬁcant diﬀerences were
detected between IVM and the control groups either in the
nuclei or in the cytoplasm (Figure 5).
3.7. Localization and Intensity of Ac-H3. No appreciable
expressionofAc-H3wasobservedinMIIoocytes.Ac-H3was
only detected in the nuclei in embryos, and no signiﬁcant
diﬀerences of ﬂuorescent intensities were found between
IVM and the control groups (Figure 6).
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Figure 4: mRNA expression of HDAC1 in oocytes and embryos.
The comparison of HDAC1 mRNA expression was made between
IVM and control groups. Summary data showed the relative
expression levels of HDAC1 in oocytes and embryos after real-time
PCR analysis. The relative mRNA levels represent the amount of
mRNA expression normalized with GAPDH.
4. Discussion
In this study, we found that histone acetylation in oocytes,
early cleavage embryos, and (two-cell embryos) was changed
in IVM group. The rates of fertilization, cleavage, and
developmental competence from two-cell to four-cell stage
were signiﬁcantly lower in IVM group, so as the birth rate
(BR) with two-cell transfer. We conﬁrmed that IVM aﬀected
the quality of oocytes during the process of epigenetic
reprogramming and led to the results above.
Although the decreased expressions of GCN5 mRNA
were detected in IVM group, no statistically diﬀerences were
shown.TheabsenceofchangeinGCN5mRNAexpressionin
both MII oocytes and two-cell embryos from IVM indicated
that IVM might not aﬀect GCN5 transcription, and the
maternally inherited GCN5 mRNAs that were transcribed
during the oocyte growth phase were abundant [30].
However, GCN5 protein expressions were decreased in
IVMoocytesandtwo-cellembryos.Thesechangesweremost
likely caused by the diﬀerence between a relatively simple
in vitro culture condition and the complex in vivo system
supported by multiple interactions of various factors and
cells in ovary [31–33]. The polarity of blastomere was funda-
mental for the subsequent development and diﬀerentiation
of the embryos [34–37]. It was reported that cytoplasm is
polarized by cortical proteins, and this polarization then
inﬂuencesthestabilityofothermaternallyexpressedproteins
that in turn determine early embryonic cell fates [35]. In
the present study, the distribution polarity of GCN5 protein
in the blastomere of two-cell embryos disappeared in the
IVM group, which might aﬀect the subsequent develop-
ment. The decreased expression and altered distribution6 Obstetrics and Gynecology International
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Figure 5: Fluorescence immunocytochemistry of HDAC1 in oocytes and embryos. (a) Expressions of HDAC1 in MII oocytes, 2-cell, 4-cell,
and 8-cell embryos from IVM and control groups. Each sample was counterstained with DAPI (blue) to visualize the DNA. Speciﬁc rabbit
polyclonal HDAC1 was detected by ﬂuorescein-conjugated antirabbit secondary antibodies (green, FITC-labeled). Bar represents 100μm.
(b) The gray value of GCN5 in oocytes and embryos.
of GCN5 in IVM oocytes and two-cell embryos suggested
that IVM could disturb the function of GCN5 during the
period of reprogramming, which might lead to epigenetic
alterations.
HDAC1 played a role in the ATP-dependent chromatin
remodeling [38], participated in the downregulation of a
variety of DNA-binding transcription factors [19, 39], and
modulated cell proliferation. The signiﬁcantly decreased
H D A C 1m R N Al e v e l si nb o t ho o c y t e sa n dt w o - c e l le m b r y o s
from IVM strongly implied that IVM procedure downregu-
lated the transcription of HDAC1 gene in oocytes before and
after fertilization. During the growth of the mammalian fol-
licular oocyte, the oocyte actively transcribed and produced
stable RNA to support early embryonic cleavage. However,
on the attainment of its full size, transcription ceased and
the previously stored mRNA derived development through
oocyte maturation, fertilization, and the early cleavage stages
up to the activation of the embryonic genome [30]. In mice,
the maternal/zygotic transition (MZT) occurs in the late
two-cell stage. The defects of HDAC1 mRNA in MII oocytes
suggested that the down-regulation of HDAC1 gene resulted
from IVM occurred at the early stage of oocyte maturation.
The low rate of developmental competence from two-cell to
four-cell embryos could be explained by the delay of zygotic
gene activation (ZGA) associated with expression alteration
of HDAC1 and/or other genes [40].Obstetrics and Gynecology International 7
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Figure6:FluorescenceimmunocytochemistryofAc-H3inoocytesandembryos.(a)ExpressionofAc-H3in2-cell,4-cell,and8-cellembryos
from IVM and control groups. Cells were immunostained with the Ac-H3 antibody. Each sample was counterstained with DAPI (blue) to
visualize the DNA. Speciﬁc rabbit polyclonal Ac-H3 was detected by ﬂuorescein-conjugated antirabbit secondary antibodies (green, FITC-
labeled). Bar represents 100μm. (b) The gray value of GCN5 in oocytes and embryos.
Gioia et al. revealed that IVM oocytes failed to acquire
full remodeling competence because of the disturbance of
acetylation [41]. HDAC1 protein in cytoplasm of two-cell
embryos was inherited from maternal storage while in the
nuclei it was synthesized by the embryos themselves [42–45].
The reduced level of HDAC1 protein expression in nuclei of
IVM 2-cell embryos suggested that IVM aﬀected the HDAC1
protein syntheses and might interrupt its nucleus-cytoplasm
distributions at this stage of embryos [20].
No diﬀerences were detected in the expression of GCN5
and HDAC1 after two-cell stage embryos, which indicated
that the insuﬃciency induced by IVM might be rectiﬁed
during the process of growing from two-cell to four-cell
stage. The signiﬁcantly lower rates of fertilization and cleav-
age in this IVM mouse model suggested that the mechanism
of selection was functioned, and the oocytes and embryos
seriously aﬀected by IVM were eliminated before the embryo
developed to two-cell stage.8 Obstetrics and Gynecology International
The level of acetyl-histone H3 is an index for the
evaluation of global histone acetylation in chromatin. H3
a c e t y l a t i o ni si n v o l v e di ng e n ee x p r e s s i o nr e g u l a t i o na n d
genome reprogramming in oocytes and embryos [46, 47].
Although IVM could aﬀect the expression and distribution
of GCN5 and HDAC1 in MII oocytes and 2-cell embryos,
which might be one reason for the low BR after 2-cell
transfer, the levels of acetyl-histone H3 were not signiﬁcantly
changed in IVM group. Thus, global histone acetylation
levels remain comparable in IVM oocytes and embryos.
Otheracetyltransferasesordeacetylasesmaycomplementthe
function of GCN5 and HDAC1 on regulation of histone
modiﬁcation [48]. The global changes of acetylation in
these residues of histone or speciﬁc changes in a target
locus of chromatins associated with CGN5 and HDAC1
will require further investigation. The seeming inconsis-
tency between GCN5/HDAC1 levels and H3 acetylation
levels is partially caused by protein localization, as IVM-
induced changes of GCN5 were observed in the cytoplasm,
while Ac-H3 is associated with chromatins that localize in
nuclei.
In conclusion, our studies showed that IVM could aﬀect
the expressions of GCN5 and HDAC1 in MII oocytes and
two-cell embryos. However, these changes appear to be
transient and normal levels resumed in later development
stages. Although recent reports had shown that IVM might
be safe to the newborn [49], the detrimental eﬀects of IVM
onthedevelopmentofembryo,fetus,orevennewborncould
not be totally ruled out. Indeed, the lower pregnancy rate
of IVM indicated that the impact of IVM procedures persist
beyond the stage of implantation. The precise mechanisms
by which IVM aﬀect, the GCN5 and HDAC1 levels and the
implication of these changes for the safety of oﬀspring need
to be investigated in future studies.
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